NCT04232917 - Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. | Biotech Hunter

Enrollment

284

Participants

Timeline

Start Date

October 17, 2020

Primary Completion Date

March 15, 2027

Study Completion Date

October 30, 2027

Conditions

Human Papilloma Virus

Interventions

DRUG

2LPAPI®

Treatment

DRUG

Placebo

Trial Locations (12)

1000

RECRUITING

CHU Saint-Pierre, Brussels

RECRUITING

Clinique St Jean, Brussels

1020

RECRUITING

CHU Brugmann, Brussels

1050

RECRUITING

Hôpitaux Iris Sud - Iris Zuid Ziekenhuis, Brussels

1340

NOT_YET_RECRUITING

Clinique Saint-Pierre Ottignies (CSPO), Ottignies

4960

ACTIVE_NOT_RECRUITING

Centre Hospital Reine Astrid Malmedy (CHRAM), Malmedy

5000

RECRUITING

Belgium, Namur

ACTIVE_NOT_RECRUITING

Belgium, Namur

RECRUITING

Cabinet privé, Namur

6042

ACTIVE_NOT_RECRUITING

Hôpital Civil Marie Curie ISPPC, Charleroi

7000

RECRUITING

CHWAPI, Tournai

Unknown

RECRUITING

UCL Namur - site Sainte Elisabeth, Namur